Harvard Teaching Hospital logo

CHA Newsroom

  • Jan 14, 2021

Boston Globe Features CHA Clinical Trial in Story on Everyday Drugs as Possible COVID-19 Treatments

Boston Globe highlights CHA COVID-19 clinical trial for NAC.

  • Jan 06, 2021

Boston Magazine Names 21 CHA Physicians to 2021 Top Doctors List

Once again, CHA makes the grade with many of our doctors honored as "Top Docs" in the Boston area.

  • Dec 30, 2020

WBUR/CommonHealth Highlights CHA COVID-19 Vaccine Education for Staff

How CHA's COVID-19 clinic got to 'Yes' on staff vaccinations.

  • Dec 20, 2020

NBC News Story on Monoclonal Antibodies as COVID-19 Treatment Features Insight From CHA Physician

A form of treatment for COVID-19 is not being used in some settings.

  • Dec 10, 2020

CHA Primary Care Physician Named 2020 Science Defender

Gaurab Basu, MD, MPH, co-director CHEEA was named a 2020 Science Defender by the Union of Concerned Scientists.

  • Nov 12, 2020

In Memoriam: Leah Zallman, MD, MPH

CHA physician Leah Zallman, MD, MPH, passed away on November 5th from injuries sustained in an accident earlier in the week.

  • Nov 04, 2020

Cambridge Health Alliance Launches Clinical Drug Trial for COVID-19 Treatment

Cambridge Health Alliance (CHA), an academic community health system serving Cambridge, Somerville and Boston's metro-north region, has launched its first-ever clinical drug trial (ClinicalTrials.gov #NCT04419025). The study explores whether N-acetylcysteine (NAC), a drug commonly used to treat acetaminophen (Tylenol) poisoning and to prevent exacerbations of COPD (emphysema), can prevent mild to moderate COVID-19 symptoms in patients from progressing to severe disease.

Affiliated with:
Teaching Hospital of:
Close